An interesting article in the latest issue of Clinica. David Nicolson, the CEO of the UK’s National Health Service (NHS) speaking at the Innovation Expo meeting stressed the importance of investing in innovation for long-term benefits and warned the NHS against isolating itself and becoming risk-averse.
Clearly the what Eucomed has been alerting policy makers to is beginning to gain traction – that it is important for policymakers to invest in and embrace new technologies. Not doing so might bring some short-term cash benefits, but in the long run it will lead to financial unsustainability and second rate health systems. Now who would want that?
– John Brennan, Director Regulatory and Technical Affairs, Eucomed